drugset
drugset / Trial / NCT01403818

A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration

NCT01403818 ↗

Phase 1 Completed 60 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

This study is to assess the pharmacokinetic interaction between ASP1941 and Mitiglinide calcium hydrate in healthy volunteers.

Timeline

Start
2011-06
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitiglinide Small molecule — Oral
Subject ipragliflozin Small molecule — Oral

Indications

No indication recorded.